Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alzheimer's disease.

D A Bennett1, D A Evans

  • 1Department of Neurological Sciences, Rush Presbyterian-St. Luke's Medical Center, Chicago, Illinois.

Disease-A-Month : DM
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Alzheimer's disease is a severe chronic illness affecting older adults, with diagnosis relying on clinical evaluation and cognitive testing. While no cure exists, interventions can improve patient and caregiver quality of life.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Direct observation of muonic molecules in resonance states critical to muon catalyzed fusion.

Science advances·2026
Same author

Harmonization of late-life participation in cognitively stimulating activities across four cohort studies of cognitive aging.

Experimental gerontology·2026
Same author

Nose-to-brain translocation of inhaled ultrafine elongated particles: facts and mysteries.

Frontiers in toxicology·2025
Same author

Most Stringent Bound on Electron Neutrino Mass Obtained with a Scalable Low-Temperature Microcalorimeter Array.

Physical review letters·2025
Same author

Few-Electron Highly Charged Muonic Ar Atoms Verified by Electronic K X Rays.

Physical review letters·2025
Same author

A Highly Linear Calibration Metric for TES X-ray Microcalorimeters.

Journal of low temperature physics·2025
Same journal

Disturbances due to cold.

Disease-a-month : DM·2026
Same journal

GLP-1 agonist and neuroprotection in Stroke and Parkinson's disease: A systematic review.

Disease-a-month : DM·2026
Same journal

GLP-1 receptor agonists for weight management and potential thromboembolic risk reduction in high risk population with cancer, diabetes, cardiovascular disease: A systematic review.

Disease-a-month : DM·2026
Same journal

Periodontal disease and diabetic kidney disease: A comprehensive analysis.

Disease-a-month : DM·2026
Same journal

Foreword for Glucagon-like peptide-1 receptor agonists (GLP-1) and its promise for potential benefits.

Disease-a-month : DM·2026
Same journal

Foreword for insulin autoimmune syndrome (Hirata Disease): An updated review of epidemiology, pathophysiology, clinical features, diagnosis, and management.

Disease-a-month : DM·2026
See all related articles

Area of Science:

  • Neurology
  • Geriatrics
  • Pathology

Background:

  • Alzheimer's disease (AD) is a prevalent, severe chronic illness disproportionately affecting older individuals.
  • Its incidence strongly correlates with age, posing a growing public health challenge as populations age.
  • Diagnosis involves clinical history, neurological exams, and cognitive function assessment, often using neuropsychological testing.

Purpose of the Study:

  • To accurately diagnose dementia and determine if it aligns with Alzheimer's disease criteria.
  • To identify alternative diagnoses, particularly in atypical presentations.
  • To evaluate coexisting conditions that may exacerbate dementia and could be treatable.

Main Methods:

  • Clinical evaluation including patient history and neurological examination.

Related Experiment Videos

  • Formal neuropsychological testing to assess cognitive function.
  • Laboratory tests to rule out other causes of dementia.

    • Main Results:

    • Definitive diagnosis of Alzheimer's disease is confirmed pathologically by neuritic plaques and neurofibrillary tangles in the brain.
    • These characteristic lesions are found in greater numbers in the neocortex and hippocampus in AD patients compared to older adults without dementia.
    • Laboratory testing primarily serves to exclude other conditions contributing to dementia, as no definitive antemortem diagnostic test for AD exists.

    Conclusions:

    • Comprehensive clinical assessment is crucial for diagnosing Alzheimer's disease and differentiating it from other dementias.
    • While effective pharmacotherapy for cognitive decline is lacking, multifaceted interventions can significantly enhance the quality of life for patients and caregivers.
    • Early diagnosis allows patients to make informed decisions about future care and life-prolonging measures.